Yang JH - Search Results

1

Cancer Screening in Patients With Multiple Sclerosis: Are We Doing Enough?

Yang JH, Graves JS. Yang JH, et al. Neurology. 2022 May 3;98(18):737-738. doi: 10.1212/WNL.0000000000200366. Neurology. 2022. PMID: 35501163 No abstract available.

2

A systematic review and quantitative synthesis of the long-term psychiatric sequelae of pediatric autoimmune encephalitis.

Nguyen L, Yang JH, Goyal S, Irani N, Graves JS. Nguyen L, et al. Among authors: yang jh. J Affect Disord. 2022 Jul 1;308:449-457. doi: 10.1016/j.jad.2022.04.027. Epub 2022 Apr 13. J Affect Disord. 2022. PMID: 35429531

3

Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms.

Shanley JE, Valenciano AF, Timmons G, Miner AE, Kakarla V, Rempe T, Yang JH, Gooding A, Norman MA, Banks SJ, Ritter ML, Ellis RJ, Horton L, Graves JS. Shanley JE, et al. Among authors: yang jh. Ann Clin Transl Neurol. 2022 Jul;9(7):995-1010. doi: 10.1002/acn3.51578. Epub 2022 Jun 15. Ann Clin Transl Neurol. 2022. PMID: 35702954 Free PMC article.

4

Therapeutic Advances in Multiple Sclerosis.

Yang JH, Rempe T, Whitmire N, Dunn-Pirio A, Graves JS. Yang JH, et al. Front Neurol. 2022 Jun 3;13:824926. doi: 10.3389/fneur.2022.824926. eCollection 2022. Front Neurol. 2022. PMID: 35720070 Free PMC article. Review.

5

The NHANES Biological Age Index demonstrates accelerated aging in MS patients.

Miner AE, Yang JH, Kinkel RP, Graves JS. Miner AE, et al. Among authors: yang jh. Mult Scler Relat Disord. 2023 Sep;77:104859. doi: 10.1016/j.msard.2023.104859. Epub 2023 Jul 7. Mult Scler Relat Disord. 2023. PMID: 37473592 Free article.

6

Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19.

Liu EN, Yang JH, Patel L, Arora J, Gooding A, Ellis R, Graves JS. Liu EN, et al. Among authors: yang jh. J Neurol. 2023 Oct;270(10):4661-4672. doi: 10.1007/s00415-023-11885-x. Epub 2023 Jul 26. J Neurol. 2023. PMID: 37493802 Free PMC article.

7

Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis.

Yang JH, Liu EN, Nguyen L, Dunn-Pirio A, Graves JS. Yang JH, et al. Neurology. 2023 Nov 27;101(22):e2300-e2313. doi: 10.1212/WNL.0000000000207746. Neurology. 2023. PMID: 37827848

8

Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis.

Siddiqui A, Yang JH, Hua LH, Graves JS. Siddiqui A, et al. Among authors: yang jh. Neurol Clin. 2024 Feb;42(1):255-274. doi: 10.1016/j.ncl.2023.07.003. Epub 2023 Aug 23. Neurol Clin. 2024. PMID: 37980118 Review.

9

Senescence marker p16INK4a expression in patients with multiple sclerosis.

Yang JH, Miner AE, Fair A, Kinkel R, Graves JS. Yang JH, et al. Mult Scler Relat Disord. 2024 Apr;84:105498. doi: 10.1016/j.msard.2024.105498. Epub 2024 Feb 11. Mult Scler Relat Disord. 2024. PMID: 38359693 Free article.

10

Analysis of Evusheld safety and efficacy in multiple sclerosis patients.

Liu EN, Real M, Yang JH, Fair A, Whitmire N, Perez A, Wilder C, Rosengren S, Kinkel RP, Graves JS. Liu EN, et al. Among authors: yang jh. Mult Scler Relat Disord. 2024 Aug;88:105733. doi: 10.1016/j.msard.2024.105733. Epub 2024 Jun 17. Mult Scler Relat Disord. 2024. PMID: 38901372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,283 results

Search Page

Filters